FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040883058> ?p ?o ?g. }

• W2040883058 endingPage "718" @default.
• W2040883058 startingPage "714" @default.
• W2040883058 abstract "Introduction: Angiogenesis is fundamental to tumour growth and vascular endothelial growth factor (VEGF) is one of the most potent proangiogenic cytokines known. We have previously demonstrated that tamoxifen reduces serum VEGF in certain cancer patients. We hypothesized that tamoxifen may attenuate the angiogenetic response to VEGF. Methods: Human dermal microvessel endothelial primary cell cultures (HMEC) were incubated with tamoxifen (1.25–5.0 μg) or vehicle. Cell proliferation was quantified using 5-bromo-2′-deoxyuridine (BrdU) labelling endothelial cell proliferation assay. The effect of oral tamoxifen (20 mg/day) on VEGF-mediated angiogenesis in vivo was assessed using a Matrigel angiogenesis assay in the Sprague–Dawley rat. Results: Tamoxifen (5.0 μg/ml) significantly reduced HMEC proliferation over 24 h when compared with cells treated with vehicle alone. Oral administration of tamoxifen in the rat (20 mg/day) significantly reduced endothelial cell proliferation and migration in response to VEGF. Conclusion: Tamoxifen (5.0 μg/ml) reduces proliferation of a VEGF-dependent endothelial cell line in vitro. In vivo, orally administered tamoxifen reduces VEGF-mediated angiogenesis in the rat. These findings indicate that tamoxifen may directly inhibit the effect of VEGF on the endothelial cell, in addition to its previously described effect of reducing serum VEGF levels. This data supports a role for tamoxifen in modulation of the VEGF-dependent angiogenic response to surgical trauma, particularly as an adjuvant therapy for VEGF-dependent tumours." @default.
• W2040883058 created "2016-06-24" @default.
• W2040883058 creator A5005506822 @default.
• W2040883058 creator A5009988219 @default.
• W2040883058 creator A5015297540 @default.
• W2040883058 creator A5033668917 @default.
• W2040883058 creator A5070788738 @default.
• W2040883058 creator A5087851676 @default.
• W2040883058 date "2001-12-01" @default.
• W2040883058 modified "2023-10-17" @default.
• W2040883058 title "Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo" @default.
• W2040883058 cites W1986445986 @default.
• W2040883058 cites W1994973424 @default.
• W2040883058 cites W1999712462 @default.
• W2040883058 cites W2028432263 @default.
• W2040883058 cites W2034394424 @default.
• W2040883058 cites W244494828 @default.
• W2040883058 cites W4255042798 @default.
• W2040883058 doi "https://doi.org/10.1053/ejso.2001.1177" @default.
• W2040883058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11735166" @default.
• W2040883058 hasPublicationYear "2001" @default.
• W2040883058 type Work @default.
• W2040883058 sameAs 2040883058 @default.
• W2040883058 citedByCount "55" @default.
• W2040883058 countsByYear W20408830582012 @default.
• W2040883058 countsByYear W20408830582013 @default.
• W2040883058 countsByYear W20408830582014 @default.
• W2040883058 countsByYear W20408830582015 @default.
• W2040883058 countsByYear W20408830582016 @default.
• W2040883058 countsByYear W20408830582017 @default.
• W2040883058 countsByYear W20408830582018 @default.
• W2040883058 countsByYear W20408830582019 @default.
• W2040883058 countsByYear W20408830582020 @default.
• W2040883058 countsByYear W20408830582021 @default.
• W2040883058 countsByYear W20408830582022 @default.
• W2040883058 crossrefType "journal-article" @default.
• W2040883058 hasAuthorship W2040883058A5005506822 @default.
• W2040883058 hasAuthorship W2040883058A5009988219 @default.
• W2040883058 hasAuthorship W2040883058A5015297540 @default.
• W2040883058 hasAuthorship W2040883058A5033668917 @default.
• W2040883058 hasAuthorship W2040883058A5070788738 @default.
• W2040883058 hasAuthorship W2040883058A5087851676 @default.
• W2040883058 hasConcept C121608353 @default.
• W2040883058 hasConcept C123012128 @default.
• W2040883058 hasConcept C126322002 @default.
• W2040883058 hasConcept C134018914 @default.
• W2040883058 hasConcept C146285616 @default.
• W2040883058 hasConcept C150903083 @default.
• W2040883058 hasConcept C167734588 @default.
• W2040883058 hasConcept C202751555 @default.
• W2040883058 hasConcept C207001950 @default.
• W2040883058 hasConcept C2776067312 @default.
• W2040883058 hasConcept C2776436680 @default.
• W2040883058 hasConcept C2777025900 @default.
• W2040883058 hasConcept C2777176818 @default.
• W2040883058 hasConcept C2778271429 @default.
• W2040883058 hasConcept C2778608917 @default.
• W2040883058 hasConcept C2780394083 @default.
• W2040883058 hasConcept C502942594 @default.
• W2040883058 hasConcept C530470458 @default.
• W2040883058 hasConcept C55493867 @default.
• W2040883058 hasConcept C62112901 @default.
• W2040883058 hasConcept C71924100 @default.
• W2040883058 hasConcept C86803240 @default.
• W2040883058 hasConcept C98274493 @default.
• W2040883058 hasConceptScore W2040883058C121608353 @default.
• W2040883058 hasConceptScore W2040883058C123012128 @default.
• W2040883058 hasConceptScore W2040883058C126322002 @default.
• W2040883058 hasConceptScore W2040883058C134018914 @default.
• W2040883058 hasConceptScore W2040883058C146285616 @default.
• W2040883058 hasConceptScore W2040883058C150903083 @default.
• W2040883058 hasConceptScore W2040883058C167734588 @default.
• W2040883058 hasConceptScore W2040883058C202751555 @default.
• W2040883058 hasConceptScore W2040883058C207001950 @default.
• W2040883058 hasConceptScore W2040883058C2776067312 @default.
• W2040883058 hasConceptScore W2040883058C2776436680 @default.
• W2040883058 hasConceptScore W2040883058C2777025900 @default.
• W2040883058 hasConceptScore W2040883058C2777176818 @default.
• W2040883058 hasConceptScore W2040883058C2778271429 @default.
• W2040883058 hasConceptScore W2040883058C2778608917 @default.
• W2040883058 hasConceptScore W2040883058C2780394083 @default.
• W2040883058 hasConceptScore W2040883058C502942594 @default.
• W2040883058 hasConceptScore W2040883058C530470458 @default.
• W2040883058 hasConceptScore W2040883058C55493867 @default.
• W2040883058 hasConceptScore W2040883058C62112901 @default.
• W2040883058 hasConceptScore W2040883058C71924100 @default.
• W2040883058 hasConceptScore W2040883058C86803240 @default.
• W2040883058 hasConceptScore W2040883058C98274493 @default.
• W2040883058 hasIssue "8" @default.
• W2040883058 hasLocation W20408830581 @default.
• W2040883058 hasLocation W20408830582 @default.
• W2040883058 hasOpenAccess W2040883058 @default.
• W2040883058 hasPrimaryLocation W20408830581 @default.
• W2040883058 hasRelatedWork W2040883058 @default.
• W2040883058 hasRelatedWork W2058103173 @default.
• W2040883058 hasRelatedWork W2328812527 @default.
• W2040883058 hasRelatedWork W2366691186 @default.
• W2040883058 hasRelatedWork W2926335606 @default.

• next